SCHEMBL30425153

SCHEMBL30425153

Nc1ncc2cc(-c3nnn(Cc4cc(F)c(-c5nnc(C(F)F)o5)cc4F)n3)ccc2n1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 12/20 0.46
▸ NPC1 O15118 3/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ NFKB2 Q00653 1/20 0.35
▸ RELA Q04206 1/20 0.35
▸ RECQL P46063 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ LCK P06239 3/20 0.33
▸ KDR P35968 2/20 0.33
▸ JAK3 P52333 1/20 0.33
▸ MAPK14 Q16539 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ KIT P10721 2/20 0.32
▸ SRC P12931 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25386312 1.00 HDAC6 (0.46) HDAC6NPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL25389287 0.90 HDAC6 (0.49) HDAC6NPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL30425027 0.90 HDAC6 (0.49) HDAC6NPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL30424974 0.88 HDAC6 (0.47) HDAC6NPC1RAB9ALCKKDR
SCHEMBL25218182 0.88 HDAC6 (0.47) HDAC6NPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL30424292 0.88 HDAC6 (0.47) HDAC6NPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL25386766 0.88 HDAC6 (0.46) HDAC6NPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL25386143 0.88 HDAC6 (0.47) HDAC6NPC1RAB9ALCKKDR
SCHEMBL30425685 0.88 HDAC6 (0.46) HDAC6NPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL25386802 0.88 HDAC6 (0.44) HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116157398-B Oxadiazole-based selective histone deacetylase 6 inhibitors 意大发马克股份公司 2025-03-11 — — CN claimed
CN-116157398-A 2- (4- ((5- (benzo [ b ] thiophen-3-yl) -1H-tetrazol-1-yl) methyl) phenyl) -5- (difluoromethyl) -1,3, 4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (HDAC 6) for the treatment of, for example, peripheral neuropathy 意大发马克股份公司 2023-05-23 — — CN claimed
CN-116157398-B Oxadiazole-based selective histone deacetylase 6 inhibitors 意大发马克股份公司 2025-03-11 — — CN disclosed
CN-116157398-A 2- (4- ((5- (benzo [ b ] thiophen-3-yl) -1H-tetrazol-1-yl) methyl) phenyl) -5- (difluoromethyl) -1,3, 4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (HDAC 6) for the treatment of, for example, peripheral neuropathy 意大发马克股份公司 2023-05-23 — — CN disclosed
Send feedback